A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
The purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine (Xeloda) provides measurable clinical benefits over capecitabine alone in women with metastatic breast cancer. Patients should have previously received an anthracycline and a taxane. The safety of this treatment will also be studied.
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Barrio Alto Verde, Córdoba Province, Argentina
Centro-Porto Alegre, Rio Grande do Sul, Brazil
Higienopolis, São Paulo, Brazil
Dilian, Liaoning, China
Crete, Greece
Wilton, Cork, Ireland
Panorama, Western Cape, South Africa
Terassa, Barcelona, Spain